ABSTRACT
INTRODUCTION Preformulation studies inevitably extend beyond the basic characterization of the lead compound, because what is considered as an acceptable characteristic of a lead compound will largely depend on the intended or anticipated dosage form. For example, the solubility issues will largely determine the route of administration; conversely, if a particular route of administration is the only desired route, then preformulation studies should attempt to find out the structural changes necessary for the candidate molecule.
